Abstract
Congestive heart failure affects 23 million people worldwide, including 7.5 million in North America (670 000 new cases per year) and 7 million in Europe [1]. Since 10% of those over 65 suffer from systolic left ventricular dysfunction, the number of patients with heart failure will double over the next 25 years. At any time, 10% of the heart failure cohort are categorized Stage D with advanced structural heart disease and symptoms at rest, despite detailed medical and cardiac resynchronization therapy. Twenty percent of these are younger than 65 years of age (around 140 000 in both the USA and Europe).

This publication has 45 references indexed in Scilit: